<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:e sem="disease" ids="C0041364" disease_type="Disease or Syndrome" abbrv="">tumour lysis syndrome</z:e> (TLS) is a group of <z:mp ids='MP_0005266'>metabolic abnormalities</z:mp> caused by rapid and unexpected release of cellular components into the circulation as a result of massive destruction of rapidly proliferating malignant cells </plain></SENT>
<SENT sid="1" pm="."><plain>It usually develops in patients with <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancies</z:e> like <z:hpo ids='HP_0006721'>acute lymphoid leukemia</z:hpo>, non-Hodgkin and Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> after initiation of chemotherapy or may, rarely, occur spontaneously </plain></SENT>
<SENT sid="2" pm="."><plain>Though TLS is seldom observed in relation to <z:e sem="disease" ids="C0280100" disease_type="Neoplastic Process" abbrv="">solid tumours</z:e>, there have been reports of connections with examples such as lung, liver, breast, gastric <z:mp ids='MP_0002038'>carcinomas</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>The clinical manifestations of TLS include <z:hpo ids='HP_0002149'>hyperuricemia</z:hpo>, <z:hpo ids='HP_0002153'>hyperkalemia</z:hpo>, <z:hpo ids='HP_0002905'>hyperphosphatemia</z:hpo> and <z:hpo ids='HP_0002901'>hypocalcemia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>These indications if untreated lead to life-threatening complications such as <z:hpo ids='HP_0001919'>acute renal failure</z:hpo>, <z:hpo ids='HP_0011675'>cardiac arrhythmias</z:hpo>, <z:hpo ids='HP_0001250'>seizures</z:hpo>, and eventually <z:hpo ids='HP_0011420'>death</z:hpo> due to multiorgan failure </plain></SENT>
<SENT sid="5" pm="."><plain>Therefore early detection of TLS is of vital importance </plain></SENT>
<SENT sid="6" pm="."><plain>This can be accomplished by identification of high risk patients, implementation of suitable prophylactic measures and monitoring of the electrolyte levels in patients undergoing chemotherapy </plain></SENT>
</text></document>